ABSI - Absci Corp logo

Absci Corp

ABSI

Absci Corporation develops antibody therapeutics using AI and synthetic biology to streamline drug discovery. Its pipeline includes candidates for inflammatory bowel disease, androgenic alopecia, and oncology, supported by collaborations with various institutions.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$804today

Score Overview

1 Year
Score
Net Growth-5.12%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-44.25%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score2.2
Net Growth-19.93%
Net Trend20%
Net Income Consistencyโ€”
Rev Growth-67.36%
Rev Trend20%
Revenue Consistencyโ€”
All Time
Score
Net Growth-19.93%
Net Trend20%
Net Income Consistency
Rev Growth-67.36%
Rev Trend20%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Absci Corp has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. ABSI does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-22
$ 9.37โ€”
1 Year2025-10-22
$ 4.29118.67%
5 Years2021-10-22
$ 11.65-19.57%
All Time2021-07-22
$ 21.59-56.60%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 1M-$ 121M$ 201M
2025$ 2M-$ 115M$ 144M
2024$ 4M-$ 103M$ 112M
2023$ 5M-$ 110M$ 97M
2022$ 5M-$ 104M$ 164M
IPO2021$ 4M-$ 100M$ 252M
ABSI - Absci Corp logo

Absci Corp fundamental performance

Between 2021 and 2025, revenue declined from $ 4M to $ 2M and net income went from -$ 100M to -$ 115M. Revenue increased in 20% of the years measured; net income in 20%.

Absci Corp currently holds a 5-year HDB Score of 2.2 out of 10. How the HDB Score is calculated.

Membership

Explore ABSI with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,119 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies